Författare: Boström Fredrik, Palmqvist Sebastian, Andersson Maria, Londos Elisabet
Titel: Lewykroppsdemens - stor risk för felbehandling och död (serie: Tema demens) 2009 nr 20 sid 1374-6
Ämnesord:
Lewykropp-sjukdom
Differentialdiagnostik
Riskfaktorer
Sök liknande artiklar
Referenser:
1.McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-72.
2.McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992;305(6855):673-8.
3.McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113-24.
4.Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34:561-6.
5.Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clarc C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 1995;45(11):1991-5.
6.Parkkinen L, Soininen H, Laakso M, Alafuzoff I. Alfa-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol. 2001;27(4):314-257.
7.Bostrom F, Jonsson L, Minthon L, Londos E. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21(2):150-4.
8.Bostrom F, Jonsson L, Minthon L, Londos E. Patients with Lewy body dementia use more resources than those with Alzheimer's disease. Int J Geriatr Psychiatry. 2007;22(8):
713-9.
9.Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The MiniMental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2002;
17(6):503-9.
10.Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15
(6):548-61.
11.Andersson M, Wiig EH, Minthon L, Londos E. A Quick Test for Cognitive Speed: a measure of cognitive speed in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen. 2007;22(4):313-8.
12.Ferman TJ, Boeve BF, Smith GE, Silber MH, Lucas JA, Graff-Radford NR, et al. Dementia with Lewy bodies may present as dementia and REM sleep behaviour disorder
without parkinsonism and hallucinations. J Int Neuropsychol Soc. 2002;8(7):907-14.
13.Piggott MA, Perry EK, Marshall ET, McKeith IG, Johnson M, Melrose HL, et al. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease. Biol Psychiatry. 1998;44(8):765-74.
14.Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Fagger S, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport. 1994;5(7):747-9.
15.Francis PT, Perry EK. Cholinergic and other neurotransmitter mechanisms in Parkinsons disease, Parkinsons disease dementia and dementia with Lewy bodies. Mov Dis. 2007;22 Suppl 17: S351.
16.McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dop_amine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6(4):305-13.
17.Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. Int J Geriatr Psychiatry. 2008;23(2):192-8.
18.Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, et al. Practic Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66:996-1002.
19.Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, et al. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem. 1990;55(4):
1454-6.
20.Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, et al. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebocontrolled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord. 2002;13(3):
183-92.
21.McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356
(9247):2031-6
22.Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M. [Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery]. No To Shinkei. 2004;56(4):351-4.
23.Folstein MF, Folstein SE, McHugh PR. »Mini-mental state«. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.
24.Maeshima S, Osawa A, Maeshima S, Osawa A, Maeshima E, Shimamoto Y, et al. Usefulness of a cube-copying test in outpatients with dementia. Brain Inj. 2004;18(9):889-98.
